| Melissa A Springmeyer, MD | |
|
2026 South Jacksonville Street, Jacksonville, TX 75766 | |
| (903) 586-5678 | |
| (903) 541-4689 |
| Full Name | Melissa A Springmeyer |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 13 Years |
| Location | 2026 South Jacksonville Street, Jacksonville, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952697872 | NPI | - | NPPES |
| P8418 | Other | TX | TMB |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | P8418 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Encompass Home Health Of East Texas | Tyler, TX | Home health agency |
| Christus Mother Frances Hospital | Tyler, TX | Hospital |
| Christus Mother Frances Hospital- Jacksonville | Jacksonville, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Christus Trinity Clinic | 3072426741 | 1227 |
News Archive
A MILabs dual-energy, ultra-high resolution U-CT system has been installed at The Hebrew University of Jerusalem Israel.
InterMune today announced that the American Journal of Respiratory and Critical Care Medicine (AJRCCM) published results from a double-blind, randomized, placebo-controlled Phase II trial evaluating pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF).
Three Boston University biomedical engineers have created a genetic dimmer switch that can be used to turn on, shut off, or partially activate a gene's function. Professor James Collins, Professor Charles Cantor and doctoral candidate Tara Deans invented the switch, which can be tuned to produce large or small quantities of protein, or none at all.
Vantia Therapeutics, an emerging pharmaceutical company developing novel, small molecule drugs targeting large, underserved medical markets, today announces it has begun its planned Phase IIb trial of its lead development compound VA106483 for nocturia.
› Verified 8 days ago
| Entity Name | Christus Trinity Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285684225 PECOS PAC ID: 3072426741 Enrollment ID: O20031204001091 |
News Archive
A MILabs dual-energy, ultra-high resolution U-CT system has been installed at The Hebrew University of Jerusalem Israel.
InterMune today announced that the American Journal of Respiratory and Critical Care Medicine (AJRCCM) published results from a double-blind, randomized, placebo-controlled Phase II trial evaluating pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF).
Three Boston University biomedical engineers have created a genetic dimmer switch that can be used to turn on, shut off, or partially activate a gene's function. Professor James Collins, Professor Charles Cantor and doctoral candidate Tara Deans invented the switch, which can be tuned to produce large or small quantities of protein, or none at all.
Vantia Therapeutics, an emerging pharmaceutical company developing novel, small molecule drugs targeting large, underserved medical markets, today announces it has begun its planned Phase IIb trial of its lead development compound VA106483 for nocturia.
› Verified 8 days ago
| Entity Name | Mother Frances Hospital Jacksonville |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952306672 PECOS PAC ID: 5597751024 Enrollment ID: O20040421001092 |
News Archive
A MILabs dual-energy, ultra-high resolution U-CT system has been installed at The Hebrew University of Jerusalem Israel.
InterMune today announced that the American Journal of Respiratory and Critical Care Medicine (AJRCCM) published results from a double-blind, randomized, placebo-controlled Phase II trial evaluating pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF).
Three Boston University biomedical engineers have created a genetic dimmer switch that can be used to turn on, shut off, or partially activate a gene's function. Professor James Collins, Professor Charles Cantor and doctoral candidate Tara Deans invented the switch, which can be tuned to produce large or small quantities of protein, or none at all.
Vantia Therapeutics, an emerging pharmaceutical company developing novel, small molecule drugs targeting large, underserved medical markets, today announces it has begun its planned Phase IIb trial of its lead development compound VA106483 for nocturia.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Melissa A Springmeyer, MD 2026 South Jacksonville Street, Jacksonville, TX 75766 Ph: (903) 586-5678 | Melissa A Springmeyer, MD 2026 South Jacksonville Street, Jacksonville, TX 75766 Ph: (903) 586-5678 |
News Archive
A MILabs dual-energy, ultra-high resolution U-CT system has been installed at The Hebrew University of Jerusalem Israel.
InterMune today announced that the American Journal of Respiratory and Critical Care Medicine (AJRCCM) published results from a double-blind, randomized, placebo-controlled Phase II trial evaluating pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF).
Three Boston University biomedical engineers have created a genetic dimmer switch that can be used to turn on, shut off, or partially activate a gene's function. Professor James Collins, Professor Charles Cantor and doctoral candidate Tara Deans invented the switch, which can be tuned to produce large or small quantities of protein, or none at all.
Vantia Therapeutics, an emerging pharmaceutical company developing novel, small molecule drugs targeting large, underserved medical markets, today announces it has begun its planned Phase IIb trial of its lead development compound VA106483 for nocturia.
› Verified 8 days ago
Dr. Kenya Sekoni Etim, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 203 Nacogdoches St Ste 280, Jacksonville, TX 75766 Phone: 903-541-5396 | |
Dr. Matthew Todd Proctor, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2026 S Jackson St, Jacksonville, TX 75766 Phone: 903-586-5678 | |
Richard M Viken, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2026 S Jackson St, Jacksonville, TX 75766 Phone: 903-586-5678 | |
Craig C Weaver, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2026 S Jackson, Jacksonville, TX 75766 Phone: 903-586-5678 | |
William Milawski, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2026 S Jackson St, Jacksonville, TX 75766 Phone: 903-586-5678 | |
Dr. Ryan Dean Ford, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2026 S Jackson St, Jacksonville, TX 75766 Phone: 903-541-4599 | |
Dr. Alison Collins, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2026 S Jackson St, Jacksonville, TX 75766 Phone: 903-586-5678 |